Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) Interest Coverage Ratio (2022 - 2025)

Historic Interest Coverage Ratio for Coeptis Therapeutics Holdings (COEP) over the last 4 years, with Q3 2025 value amounting to 39.56.

  • Coeptis Therapeutics Holdings' Interest Coverage Ratio rose 593.02% to 39.56 in Q3 2025 from the same period last year, while for Sep 2025 it was 47.12, marking a year-over-year decrease of 3866.36%. This contributed to the annual value of 25.38 for FY2024, which is 8728.16% up from last year.
  • Per Coeptis Therapeutics Holdings' latest filing, its Interest Coverage Ratio stood at 39.56 for Q3 2025, which was up 593.02% from 66.7 recorded in Q2 2025.
  • Coeptis Therapeutics Holdings' 5-year Interest Coverage Ratio high stood at 14.58 for Q1 2024, and its period low was 399.05 during Q3 2023.
  • For the 4-year period, Coeptis Therapeutics Holdings' Interest Coverage Ratio averaged around 118.95, with its median value being 66.7 (2025).
  • In the last 5 years, Coeptis Therapeutics Holdings' Interest Coverage Ratio tumbled by 98485.6% in 2023 and then surged by 9299.73% in 2024.
  • Coeptis Therapeutics Holdings' Interest Coverage Ratio (Quarter) stood at 22.43 in 2022, then plummeted by 984.86% to 243.35 in 2023, then soared by 88.7% to 27.5 in 2024, then plummeted by 43.87% to 39.56 in 2025.
  • Its Interest Coverage Ratio was 39.56 in Q3 2025, compared to 66.7 in Q2 2025 and 56.75 in Q1 2025.